With solid evidence showing punitive approaches to drugs do not work, the question that arises is what to do instead? In this first instalment of a Matters of Substance series on innovative drug policies in different countries, we look at Portugal – the small European country heralded as having a particularly successful drug harm-reduction approach.
Portugal’s drug policy reforms stemmed from past concerns about it having one of the worst drug problems in Europe, notably a heroin epidemic. Reports revealed almost 1 percent of the population suffered from drug dependency in 1999, and a new approach was needed.
In 2001, Portugal both decriminalised minor drug offences for all drugs and significantly scaled up public health and social support activities under a five pillar model of prevention, drug use dissuasion, harm reduction, treatment and reintegration.
Portugal’s drug policies were refocused on a public health model with significant state financial investment in drug harm- reduction activities. These included:
Overall, while Portugal’s drug use rates went up and down after its reforms, they were followed by dramatic reductions in drug-related harms, increased social inclusion and significantly reduced social costs. Since the new approach, changes include:
Zeeshan Aleem, ‘14 Years After Decriminalising All Drugs, Here’s What Portugal Looks Like’, Policy.Mic
Niamh Eastwood, Edward Fox and Ari Rosmarin, ‘A Quiet Revolution: Drug Decriminalisation Across The Globe’
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), ‘Statistical Bulletin 2016’ EMCDDA
Johann Hari, Chasing the Scream (United Kingdom: Bloomsbury, 2015).
Caitlin Hughes and Alex Stevens, ‘Decriminalisation and public health: the Portuguese approach to drug policy’, Academia
Caitlin Hughes and Alex Stevens, ‘A resounding success or a disastrous failure: Re-examining the interpretation of evidence on the Portuguese decriminalisation of illicit drugs’, University of Kent
SICAD, ‘Annual Report 2013: The country's situation on drug matters and drug addiction’, SICAD, (2014),
United Nations Commission on Narcotic Drugs, ‘Side event: A public health approach for drug policy: The Portuguese case’, CND Blog
A new report shows New Zealand’s failure to adequately diagnose and treat ADHD is likely leading to significant drug harm, including from alcohol and nicotine.
Our latest report pulls together international evidence and local experiences of how neurodivergence impacts drug use
‘Microdosing’ psychedelics involves taking small, repeated doses of a psychedelic drug. Researcher Robin Murphy talks us through the latest Auckland University microdosing study.